Feasibility, Outcomes, and Safety of Telehepatology Services During the COVID‐19 Pandemic
Nipun Verma, Saurabh Mishra, Surender Singh, Rajwant Kaur, Talwinder Kaur, Arka De, Madhumita Premkumar, Sunil Taneja, Ajay Duseja, Meenu Singh, Virendra Singh – 20 April 2021 – Coronavirus disease 2019 (COVID‐19) has hampered health care delivery globally. We evaluated the feasibility, outcomes, and safety of telehepatology in delivering quality care amid the pandemic. A telemedicine setup using smartphones by hepatologists was organized at our tertiary‐care center after pilot testing. Consecutive patients availing telehepatology services were recruited between March and July 2020.